| M group (n = 33) | BF group (n = 33) | MBF group (n = 33) |
---|---|---|---|
Female, % | 75.8 | 69.7 | 69.7 |
Age, yr | 32.0 (27.5–52.0) | 42.0 (33.5–51.0) | 37.0 (29.0–54.5) |
BMI | 22.4 ± 3.2 | 22.7 ± 3.2 | 23.1 ± 3.2 |
Cough duration, mon | 12.0 (3.8–36.3) | 12.0 (4.0–40.5) | 18.0 (3.5–67.0) |
AR, % | 50.0 | 57.6 | 51.5 |
Atopy, % | 76.9 | 64.0 | 75.0 |
VAS | 6.0 (5.0–7.0) | 5.0 (5.0–9.0) | 6.0 (5.0–8.0) |
Daytime cough symptom score | 2.0 (2.0–3.0) | 2.0 (2.0–3.0) | 2.0 (2.0–3.0) |
Night-time cough symptom score | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 1.0 (1.0–2.0) |
Log C5 | 1.2 (0.3–2.4) | 1.8 (1.0–2.7) | 1.8 (0.7–2.2) |
FeNO | 3.8 ± 0.6 | 4.1 ± 0.6 | 3.6 ± 0.6 |
Sputum Eos% | 13.6 (2.0–37.6) | 16.1 (4.5–31.5) | 5.8 (1.3–14.5) |
Blood Eos% | 4.5 (2.1–7.2) | 4.9 (3.3–8.4) | 4.3 (3.0–7.4) |
FEV1 pred% | 93.3 ± 12.1 | 93.3 ± 12.1 | 94.6 ± 12.1 |
FEV1/FVC% | 79.1 ± 8.0 | 78.5 ± 7.9 | 77.2 ± 8.0 |
MMEF% | 64.1 ± 21.8 | 63.7 ± 21.5 | 56.3 ± 21.7 |
PD20 | 0.8 (0.3–2.4) | 0.8 (0.2–2.2) | 0.6 (0.2–1.8) |